DECOPHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
DECOPHARMA
Largest movements
- Cash -€75,398
down €75,398 (-91.8%), from €82,135 to €6,737
mainly Contributions, distributions and other (-€358,823) and Investment in fixed assets (net) (-€51,436)
- Tangible fixed assets +€42,373
up €42,373 (+80.9%), from €52,368 to €94,741
of which Furniture and vehicles: +€47,061
- Reserves -€192,171
down €192,171 (-15.1%), from €1.3m to €1.1m
of which Distributable reserves: -€192,171
- Other debts +€144,021
up €144,021 (+176.2%), from €81,747 to €225,768
- Tax, wage and social debts +€22,972
up €22,972 (+258.8%), from €8,877 to €31,849
- Gross operating margin +€19,752
up €19,752 (+8.6%), from €230,699 to €250,451
- Taxes -€13,588
down €13,588 (-19.4%), from €69,877 to €56,289
- Financial charges +€9,349
up €9,349 (+173.0%), from €5,403 to €14,752
- Depreciation +€2,627
up €2,627 (+40.8%), from €6,436 to €9,063
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,381,286 | €1,355,940 | -€25,347 | -1.8% |
| Fixed assets | 21/28 | €1,296,109 | €1,338,482 | +€42,373 | +3.3% |
| Tangible fixed assets | 22/27 | €52,368 | €94,741 | +€42,373 | +80.9% |
| Land and buildings | 22 | €46,125 | €41,726 | -€4,398 | -9.5% |
| Plant, machinery and equipment | 23 | €5,970 | €5,679 | -€291 | -4.9% |
| Furniture and vehicles | 24 | €274 | €47,335 | +€47,061 | +17175.1% |
| Financial fixed assets | 28 | €1,243,741 | €1,243,741 | = | 0.0% |
| Current assets | 29/58 | €85,178 | €17,458 | -€67,719 | -79.5% |
| Amounts receivable within one year | 40/41 | €3,043 | €10,721 | +€7,678 | +252.3% |
| Other amounts receivable | 41 | €3,043 | €10,721 | +€7,678 | +252.3% |
| Cash at bank and in hand | 54/58 | €82,135 | €6,737 | -€75,398 | -91.8% |
| Total equity and liabilities | 10/49 | €1,381,286 | €1,355,940 | -€25,347 | -1.8% |
| Equity | 10/15 | €1,289,551 | €1,097,380 | -€192,171 | -14.9% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,270,951 | €1,078,780 | -€192,171 | -15.1% |
| Non-distributable reserves | 130/1 | €12,077 | €12,077 | = | 0.0% |
| Reserves not available under the articles | 1311 | €12,077 | €12,077 | = | 0.0% |
| Distributable reserves | 133 | €1,258,874 | €1,066,703 | -€192,171 | -15.3% |
| Amounts payable | 17/49 | €91,736 | €258,560 | +€166,824 | +181.9% |
| Amounts payable within one year | 42/48 | €90,985 | €257,776 | +€166,791 | +183.3% |
| Trade debts | 44 | €362 | €159 | -€202 | -55.9% |
| Suppliers | 440/4 | €362 | €159 | -€202 | -55.9% |
| Taxes, remuneration and social security | 45 | €8,877 | €31,849 | +€22,972 | +258.8% |
| Taxes | 450/3 | €8,877 | €31,849 | +€22,972 | +258.8% |
| Other amounts payable | 47/48 | €81,747 | €225,768 | +€144,021 | +176.2% |
| Accrued charges and deferred income | 492/3 | €751 | €784 | +€33 | +4.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €6,436 | €9,063 | +€2,627 | +40.8% |
| Other operating charges | 640/8 | €1,678 | €3,695 | +€2,016 | +120.1% |
| Gross operating margin | 9900 | €230,699 | €250,451 | +€19,752 | +8.6% |
| Operating profit (loss) | 9901 | €222,585 | €237,694 | +€15,109 | +6.8% |
| Financial income | 75/76B | €0 | - | -€0 | |
| Recurring financial income | 75 | €0 | - | -€0 | |
| Financial charges | 65/66B | €5,403 | €14,752 | +€9,349 | +173.0% |
| Recurring financial charges | 65 | €5,403 | €14,752 | +€9,349 | +173.0% |
| Profit (loss) for the period before taxes | 9903 | €217,182 | €222,941 | +€5,760 | +2.7% |
| Income taxes | 67/77 | €69,877 | €56,289 | -€13,588 | -19.4% |
| Profit (loss) for the period | 9904 | €147,305 | €166,653 | +€19,348 | +13.1% |
| Profit (loss) for the period to be appropriated | 9905 | €147,305 | €166,653 | +€19,348 | +13.1% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.